Long acting injectable buprenorphine: Perspectives from service-users, staff and stakeholders

Long acting injectable buprenorphine: Perspectives from service-users, staff and stakeholders

Introduction: Long-acting injectable buprenorphine (LAIB) is a relatively novel pharmacological treatment for people with opioid dependence. Despite growing qualitative evidence, there is limited research on practitioner insights, and effectiveness of LAIB in a community setting. Methods: Thirteen s...

Full description

Saved in:
Bibliographic Details
Main Authors: Rebecca Fish, Céu Mateus, Hannah Maiden, Euan Lawson, Mark Limmer
Format: Article
Language:English
Published: Elsevier 2025-06-01
Series:Drug and Alcohol Dependence Reports
Subjects:
Opioid agonist therapy
Long acting injectable buprenorphine
Recovery
Harm reduction
Qualitative
Online Access:http://www.sciencedirect.com/science/article/pii/S2772724625000113
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items